Newborns in the neonatal intensive care unit often face serious infections called sepsis. Doctors frequently start strong antibiotics to fight these germs. But using too many of these powerful drugs can lead to resistance and other problems. A team is testing a new approach in five hospitals in the Suqian region of China. These areas face resource limits that make standard care harder to provide. The plan bundles several steps to help doctors use antibiotics only when truly needed. It includes checking risk levels early and reviewing the need for drugs after two to three days. The team also uses a two-tier governance structure to keep everyone on track. They will run monthly cycles to review progress and make adjustments as needed. This method aims to lower the rate of antibiotic use and the number of days patients spend on therapy. The study will also look at whether infections return or if babies pass away during their hospital stay. Safety is a top priority, though no specific side effects have been reported yet because the work is still happening. This project will help other hospitals in similar settings find ways to use these medicines more wisely.
A new plan aims to cut unnecessary antibiotics for sick newborns in China
Photo by Teslariu Mihai / Unsplash
What this means for you:
A new plan in China aims to reduce antibiotic use for newborns with sepsis while keeping them safe. More on Sepsis
Maintaining gut microbiome integrity should be a fundamental component of antimicrobial stewardship strategies aimed at controlling AMR worldwide Doctors suggest fixing gut bugs is key to fighting antibiotic resistance globally
Frontiers · Jun 3, 2026
Source control and antibiotic stewardship remain cornerstones of sepsis management Review prioritizes antibiotic stewardship over live probiotics for sepsis
Frontiers · Jun 3, 2026
Narrative review discusses Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis risks from various medications A review explains which drugs may cause severe skin reactions like Stevens-Johnson Syndrome
Frontiers · Jun 2, 2026
Interleukin-7 therapy improves lymphocyte counts in sepsis and COVID-19 patients Recombinant human interleukin-7 boosts white blood cells but does not save lives in sepsis or COVID-19
· Jun 1, 2026